Ballicules.com

Digoxin immune Fab

DIGIFAB

What it isDigoxin-specific antibody fragments; digoxin toxicity.

Why this oneIt binds digoxin directly and reverses arrhythmia and hyperkalemia within an hour.

What limits itTotal digoxin assays become useless afterwards because they measure bound drug. Rebound toxicity if dosing is inadequate.

FDA label

FDA dosingPopulationStartTargetMax
Digoxin toxicity — acute ingestion, unknown amount, no serum levelAll20 vials IV (children <20 kg: start 10 vials, then 10 more if needed)
Chronic digoxin toxicity — no serum levelAdults & children ≥20 kg6 vials IV
Chronic digoxin toxicity — no serum levelInfants & children <20 kg1 vial IV
Acute ingestion of known amountAllVials = mg digoxin ingested ÷ 0.5 mg/vial
Chronic toxicity with known serum levelAllVials = (serum digoxin ng/mL × weight kg) ÷ 100

Renal Fab fragments are eliminated renally; impaired renal function may prolong elimination — monitor for recurrent toxicity.

Hepatic Undefined

Dose according to the amount of digoxin to be neutralized (0.5 mg neutralized per vial).

Instructions

Cautions

Adverse reactions

Pregnancy No human or animal data; use only if clearly needed.

Lactation Unknown whether excreted in human milk; exercise caution in nursing mothers.

NO BOXED WARNINGS

Principal riskDigoxin assays become uninterpretable afterwards

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Digoxin immune Fab ballicule

Digoxin immune Fab ballicule: receptor binding, kinetics and half-life diagram

Open Digoxin immune Fab in the interactive console ↗